O
€70–75K / year · München, Bavaria, DE
DB
Differential Bio builds a Virtual Scale-up Platform combining robotic lab automation, microbiology and AI to predict and optimise microbial bioprocesses across scale-up stages.
2 open jobs
Orbem
Orbem, a Technical University of Munich spin-off, combines rapid MRI with deep learning to inspect biological materials non-destructively across food, agriculture and human health.
Orbem, founded in 2019 as a spin-off from the Technical University of Munich, applies rapid magnetic resonance imaging combined with advanced deep learning to biological materials. The company's stated aim is to make MRI fast, accessible and simple, and to extract hidden biological information at industrial scale. It employs more than 200 people and operates from Munich, Germany, and Houston, USA.
The firm's Genus product family is an AI-powered imaging platform that provides non-destructive inside-out inspection of biological materials. Applications span poultry, fruits, nuts and human health. The technology sits at the intersection of magnetic resonance imaging, deep learning, computer vision and non-destructive testing, and is aimed at customers in food and agriculture as well as human health.
Orbem frames its work against two large-scale problems: some 1.25 billion tonnes of produce are lost annually between harvest and retail, and the global population to be fed sustainably is projected to reach 10 billion people by 2050. The company describes itself as mission-driven, with stated commitments to ethical production, planetary health and radical transparency - what it calls "inside-out intelligence" - alongside commercial value creation.